Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus (opens ClinicalTrials.gov)
- Sponsor
- Rezera (formerly NodThera Limited)
- Enrolment
- 176
- Started
- 2025-05-08
- Last update
- 2026-09-15
Conditions: Obesity and Type 2 Diabetes
Interventions: NT-0796, Placebo